Timing clarification: As of Friday, July 31, 2026, Cboe is scheduled to report this morning before the U.S. market opens, not “tomorrow.” Published calendars list a consensus EPS estimate of $3.46; a separate consensus feed lists expected revenue of approximately $714 million. (kiplinger.com)
Cboe enters 2Q with an unusually visible fundamental setup: reported monthly statistics imply another record quarter for U.S. options volumes, particularly proprietary index options and SPX 0DTE. The main debate is therefore less about whether Cboe posts strong year-over-year growth, and more about:
My base case is for a solid beat-or-meet quarter driven by derivatives, with the stock reaction determined primarily by the trajectory of 2H volume/RPC, Data Vantage growth, and any change to FY26 guidance.
| Metric | 2Q25 actual | 2Q26 consensus / setup | Investor read-through |
|---|---|---|---|
| Adjusted diluted EPS | $2.46 | $3.46 consensus | Implies roughly 41% year-over-year growth |
| Net revenue | $587.3M | ~$714M consensus | Implies roughly 22% growth |
| Options net revenue | $364.8M | Key upside driver | Proprietary-index mix should be highly favorable |
| Total Cboe options ADV | 17.3M contracts | 21.9M in 2Q26 | Record quarter; up ~27% year over year |
| Index-options ADV | 4.7M contracts | 6.2M in 2Q26 | Record level; higher-value volume mix |
| Total options RPC | $0.300 | $0.317 projected | Supports both revenue growth and mix-led monetization |
Note: “net revenue” is Cboe’s revenue less cost of revenues measure. Consensus figures are third-party published estimates; Cboe does not provide quarterly EPS or revenue guidance.
Cboe has already disclosed that total options ADV reached a record 21.9 million contracts in 2Q26, including a record 15.7 million in multi-listed options and 6.2 million in proprietary index options. SPX ADV reached a record 5.1 million, while SPX 0DTE ADV reached 3.1 million for the quarter. (ir.cboe.com)
That is important because Cboe’s index franchise is structurally more valuable than its multi-listed business:
Bottom line: Volume and pricing/mix both appear supportive. Using Cboe’s disclosed volumes and preliminary RPCs, options transaction-and-clearing revenue should grow materially faster than the 2Q25 base.
The options industry’s 2Q ADV rose more than 19% year over year to 72.8 million contracts, led by index and ETF products. Index-option volume grew 25% year to date, and 0DTE volume rose 46.2% year to date to more than 20 million contracts per day. (cboe.com)
For Cboe, the key distinction is that its proprietary SPX complex is central to this trend. The company reported a June single-day record of 7.8 million SPX contracts, including a record 3.3 million daily SPX 0DTE ADV for the month. (ir.cboe.com)
Investors should focus on whether management characterizes 0DTE demand as: - durable institutional hedging and tactical risk management, - broadening retail adoption, - or a more event- and volatility-dependent surge.
The more management emphasizes breadth, repeat participation, and Global Trading Hours adoption, the more credible the long-term earnings-power argument becomes.
The derivative result will dominate, but the quarter appears broad-based:
In 1Q26, Cboe reported record net revenue across every principal operating segment: Options, North American Equities, Europe/APAC, and Global FX. That broad strength matters because it reduces reliance on a single volatility-driven derivatives quarter.
Cboe’s share price closed July 30 at $296.56, up approximately 18% year to date, although it remains below its May 2026 peak. The stock has recovered sharply from its late-June low, suggesting investors have already recognized the favorable Q2 volume data.
That makes the post-print reaction likely to hinge on forward indicators, not the backward-looking headline alone:
In 1Q26, Cboe delivered $728.9 million of net revenue, 29% growth, and adjusted EPS of $3.70, while raising its FY26 organic-growth target and lowering expense guidance. That creates a challenging comparison in terms of investor sentiment: a good 2Q print may not be enough if management’s outlook becomes more cautious.
The company’s current full-year framework calls for:
A simple reaffirmation would be defensible given the 1H strength, but it may be viewed as conservative if management sees a normalizing volume environment in the back half.
A raise would likely require confidence in three areas:
The bull-case argument is strengthened by the structural depth of options demand: Cboe’s own industry data points to growth across index, ETF, retail, institutional block, and FLEX options activity—not merely a narrow burst in a handful of retail names. (cboe.com)
The risk is that Cboe frames 2Q as a period of extraordinary market activity rather than a run-rate. In that scenario, even an EPS/revenue beat could be offset by:
The preliminary 2Q total-options RPC projection of $0.317 is the most important near-term monetization indicator. Investors should distinguish between: - a volume-led beat with stable economics, and - a stronger outcome driven by a higher index-options mix or better-than-expected RPC.
A final figure materially below $0.317 would be a negative surprise even if ADV remains excellent. (ir.cboe.com)
Data, access, and capacity revenues are a crucial recurring-revenue offset to trading cyclicality. In 1Q, Data Vantage net revenue grew 19% year over year. Sustaining low-double-digit organic growth would validate the higher-quality portion of the earnings story.
Cboe’s 1Q strategic realignment included a planned workforce reduction of approximately 20% and an expected $20 million–$25 million of FY26 savings. Investors should look for: - realization timing, - incremental restructuring costs, - reinvestment needs in clearing, event markets, tokenization, sales, and product development, and - whether the expense range can remain intact amid strong variable compensation.
Cboe launched Cboe Predicts in June, starting with binary XSP-based contracts available through Interactive Brokers, with Charles Schwab expected to follow. The initiative is strategically relevant because it extends Cboe’s SPX ecosystem and targets outcome-based retail demand, but it is too early to be material to 2Q financials. (ir.cboe.com)
The useful call questions are about distribution, liquidity formation, regulatory positioning, product cadence, and the economics over time—not near-term revenue contribution.
Cboe ended 1Q with roughly $2.1 billion of cash and $1.44 billion of debt. It also recently established a $400 million five-year revolving credit facility, expandable by up to $200 million subject to lender agreement. The facility improves flexibility for clearing-related needs, capital returns, or strategic investment; it does not, by itself, signal an imminent acquisition.
| Scenario | What the report looks like | Likely investor reaction |
|---|---|---|
| Bull | Clear EPS/revenue beat; strong Data Vantage; final options RPC at/above $0.317; guidance raised or tone notably more confident | Shares move higher; investors underwrite a more durable earnings base |
| Base | Meets or modestly beats; derivative strength broadly as disclosed; guidance reaffirmed | Muted-to-positive response; stock reaction depends on 2H volume commentary |
| Bear | Good headline result but weaker RPC, softer non-derivatives revenue, higher expenses, or cautious outlook | Shares decline as investors de-rate the visibility of 2026–27 earnings power |
Cboe appears positioned for another strong quarter, with the core numbers largely de-risked by record disclosed volume statistics. The more consequential question is whether Q2 demonstrates that Cboe’s earnings power has structurally stepped higher through proprietary-index options, 0DTE adoption, Data Vantage, clearing, and operating leverage—or whether the quarter represents a favorable but less repeatable market-activity peak.
For investors, the highest-value signals will be:
This preview is for informational purposes only and is not investment advice.